How climate change may have caused flooding in Roswell ...

Full Story: <a href=" ...

Celebrity birthdays for the week of Oct. 27-Nov. 2 ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients ...

Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen. This is compared to 83% ...

Clinical trial shows new immunotherapy with nivolumab raised survival rates to 92% for advanced Hodgkin lymphoma patients.

We’re a long way from 2015. Nine years ago, Barack Obama rolled up to a soundproofed garage outside the comedian Marc Maron’s ...

Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma is treated in newly diagnosed adolescents and adults.

Immunotherapy has set a new standard in treating Hodgkin lymphoma, showing a 92% survival rate and fewer long-term side effects, with FDA approval anticipated soon. A new treatment that activates the ...

In mid-2023, the SWOG S1826 phase 3 trial in advanced Hodgkin lymphoma reported highly positive primary results earlier than expected, after the trial’s second planned interim analysis found the ...